Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Stick to gentle, easily digestible whole foods for week one
The LEADER trial with liraglutide and the REWIND trial with dulaglutide did not show significant increases in retinopathy complications, though differences in trial design, patient populations, baseline retinopathy prevalence, and rates of glycemic improvement may explain these discrepant findings
With ongoing treatment and lifestyle changes, many people lose 1015% or more of their starting body weight
The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans
Lifestyle strategies smaller meals, ginger, hydration, avoiding fatty foods, staying upright after eating are usually sufficient
Results Disclaimer: Individual results vary based on baseline health status, specific health goals, protocol adherence, and numerous other factors
